Home > Healthcare > Medical Devices > Diagnostic Devices > Bioimpedance Analyzer Market

Bioimpedance Analyzer Market Size

  • Report ID: GMI9189
  • Published Date: Apr 2024
  • Report Format: PDF

Bioimpedance Analyzer Market Size

Bioimpedance Analyzer Market was valued at USD 515.3 million in 2023 and is growing at a CAGR of 10.4% between 2024 and 2032. Growing awareness for health and fitness, growing demand for body composition monitoring in sports and fitness clubs, and an increase in lifestyle disorders are fuelling the growth in industry. Additionally, growth in fitness clubs, sports rehabilitation centers, and weight loss centers are also adding to the revenue growth in the global market.

 

Bioimpedance analyzers are used for measuring the body's impedance to electrical flow to measure body composition parameters such as muscle mass, water content, and fat percentage, among others. Rising lifestyle-related health issues like obesity, diabetes, and cirrhosis are straining healthcare globally, prompting a surge in demand for bioimpedance analyzers. According to the World Health Organization (WHO), obesity rates have doubled since 1990, with around 12.5% of the global population affected in 2022. Consequently, hospitals, clinics, fitness centers, and wellness programs are increasingly utilizing these analyzers to monitor body composition and track weight loss progress.
 

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Industry size for bioimpedance analyzer was recorded USD 515.3 million in 2023 and will grow at a 10.4% CAGR between 2024 and 2032 owing to heightened emphasis on health and wellness across demographics coupled with the technological advancements improving the accuracy and efficiency of bioimpedance analyzers.

The segmental body measurement segment secured USD 397.8 million in 2023, attributed to its pivotal role in providing precise assessments of body composition, including fat mass, lean body mass, and hydration levels.

North America industry will register 474.5 million by 2032, driven by heightened consciousness surrounding health and wellness endeavors, substantial expansion within the wellness and fitness sector, and the implementation of policies advocating for preventive healthcare and wellness initiatives.

Major companies operating in the bioimpedance analyzer industry are Akern, Biodynamics Corporation, Biotekna, Bodystat Ltd., Charder Electronic Co. Ltd., Evolt 360, Fook Tin Technologies Ltd., Inbody Co. Ltd., Maltron International, Omron Corporation, RJL Systems, Inc., SECA GmbH & Co. KG, Selvas Healthcare, Tanita Corporation, Xiaomi among others

Bioimpedance Analyzer Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 463
  • Countries covered: 12
  • Pages: 266
 Download Free Sample